Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial

MLA

Vicky Goh, et al. “Diagnostic Accuracy of Whole-Body MRI versus Standard Imaging Pathways for Metastatic Disease in Newly Diagnosed Colorectal Cancer: The Prospective Streamline C Trial.” The Lancet Gastroenterology & Hepatology, vol. 4, July 2019, pp. 529–37. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....31de387a268225c5c35050cd5154377f&authtype=sso&custid=ns315887.

APA

Vicky Goh, Alistair Rienhardt, Priya Limbu, Veronica A. Morgan, Beth Shepherd, David J. Breen, Kayleigh Gilbert, Paul Nichols, Lisa Woodrow, Neal Navani, Sophia Hans, Stephen Karp, Ruth E.C. Evans, Chris Everitt, Andrew Gogbashian, Elizabeth Chang, Nina Tunariu, Amelia Daniel, Elizabeth Hadley, … Lara Curry. (2019). Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. The Lancet Gastroenterology & Hepatology, 4, 529–537.

Chicago

Vicky Goh, Alistair Rienhardt, Priya Limbu, Veronica A. Morgan, Beth Shepherd, David J. Breen, Kayleigh Gilbert, et al. 2019. “Diagnostic Accuracy of Whole-Body MRI versus Standard Imaging Pathways for Metastatic Disease in Newly Diagnosed Colorectal Cancer: The Prospective Streamline C Trial.” The Lancet Gastroenterology & Hepatology 4 (July): 529–37. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....31de387a268225c5c35050cd5154377f&authtype=sso&custid=ns315887.